Algert Global’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-167,546
Closed -$519K 1373
2021
Q4
$519K Sell
167,546
-177,748
-51% -$598K 0.06% 524
2021
Q3
$1.25M Buy
345,294
+95,984
+38% +$362K 0.17% 156
2021
Q2
$893K Sell
249,310
-94,900
-28% -$335K 0.3% 116
2021
Q1
$1.35M Buy
344,210
+169,040
+97% +$698K 0.43% 72
2020
Q4
$736K Buy
175,170
+92,750
+113% +$357K 0.21% 170
2020
Q3
$307K Buy
82,420
+2,070
+3% +$8.81K 0.1% 257
2020
Q2
$350K Sell
80,350
-12,537
-13% -$56.3K 0.12% 247
2020
Q1
$352K Buy
92,887
+31,487
+51% +$155K 0.15% 222
2019
Q4
$388K Buy
61,400
+31,630
+106% +$186K 0.12% 236
2019
Q3
$125K Buy
+29,770
New +$127K 0.05% 314

Other funds holding BDSI

Algert Global's BDSI Position: Q1 2022 in Review

Algert Global sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 167,546 shares — an estimated $519K sold.

Algert Global first reported a position in BDSI in Q3 2019 and held it in 10 quarters. The position peaked at $1.35M in Q1 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Algert Global reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Algert Global sold 167,546 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $519K.
  • Algert Global first reported a position in BioDelivery Sciences International, Inc. in Q3 2019 and held it in 10 quarters.
  • Algert Global's BioDelivery Sciences International, Inc. position peaked at $1.35M in Q1 2021.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Algert Global's 13F filing for Q1 2022, filed 16 May 2022.